Press kit

Vivo Barefoot

FootwearLondon, London, England, UK

www.vivobarefoot.com

five hundred brands copied the shoe. none of them can copy the papers.

Five years ago today a Nature-portfolio journal published a study showing six months in Vivobarefoot shoes raised foot strength 57.4%. A second paper, part-funded by Innovate UK with a consultant geriatrician among its authors, found people with a history of falls stood and walked measurably more stably in them. Britain now counts 72,000 hip fractures a year at £1.1bn. Vivobarefoot is running an NFL campaign.

Five years ago today, on 20 September 2021, the journal Scientific Reports published "Daily activity in minimal footwear increases foot strength" by Curtis, Willems, Paoletti and D'Août. Twenty-two adults wore Vivobarefoot Stealth II shoes for six months and recorded an average 57.4% increase in foot strength at p less than 0.001, against a control group of twenty-four who did not. It was not the first time the company's footwear had appeared in a peer-reviewed result. In December 2020 the same journal published "Minimal shoes improve stability and mobility in persons with a history of falls" by Tomasz Cudejko, James Gardiner, Asangaedem Akpan and Kristiaan D'Août, in which thirty adults with a mean age of 68.6, all of whom had fallen since turning 60, were measured barefoot, in a conventional walking shoe and in a Vivobarefoot Primus Knit. Postural stability was significantly better in the minimal shoe than the conventional shoe in every direction measured, walking stability in the fore-aft direction was better at p less than 0.001, and the Timed Up and Go clinical mobility test was completed around 0.3 seconds faster. The paper's competing interests statement records that three of its four authors hold a mutual grant with Vivobarefoot Ltd as industrial partner, on a project funded by Innovate UK, part of UK Research and Innovation, under grant number 1570. These are laboratory measurements of stability and mobility taken on the day of testing, in people who had already fallen. They are not evidence that the footwear prevents falls, and no claim to that effect is made here or anywhere in this kit. The wider context has moved considerably since. NICE published guideline NG249 on falls assessment and prevention on 29 April 2025, the Royal College of Podiatry published a falls prevention policy on 7 July 2025 costing falls to the NHS at £4.4bn a year, and the Royal College of Physicians published its National Hip Fracture Database annual report on 10 September 2026, recording more than 72,000 hip fractures a year, around one in thirty hospital beds, £1.1bn in annual NHS cost and a further £1.25bn in social care within 120 days of injury. In the United States, the Centers for Disease Control and Prevention reports that falls are the leading cause of injury death among adults aged 65 and over, that more than fourteen million older adults report falling each year, that there were approximately 4.5 million emergency department visits for older adult falls in 2024, and that falls caused over 43,000 deaths in that year. Vivobarefoot, founded in 2012 by seventh-generation shoemakers Galahad and Asher Clark and now past €100m in turnover, launched a health education platform called VivoHealth in 2022, offering courses under names including Running Fundamentals and Holistic Health. Its current global campaign, Weird More, launched in September 2026 through Thingy and Thingy and produced by DROOL, and stars the NFL player Mack Hollins.

Trend context

Three dated things collide this month. The Curtis paper is five years old today (Scientific Reports, 20 Sept 2021). The Royal College of Physicians published the national hip fracture audit on 10 September 2026, counting more than 72,000 fractures a year, one in thirty hospital beds, £1.1bn NHS and £1.25bn social care. Vivobarefoot launched its Weird More global campaign in September 2026. Underneath all three, the barefoot category has grown from around twenty brands to more than five hundred in four years, per Galahad Clark to FashionNetwork on 3 September 2026, which makes published evidence the only part of the business that cannot be copied.

About Vivo Barefoot

Why we exist

Feet are load-bearing biological equipment, and the shoe industry has spent a century treating them as a problem to be corrected with foam. Vivobarefoot exists because two members of a seventh-generation shoemaking family concluded the family trade had it backwards. The conviction is that a foot allowed to work gets stronger, and a foot supported into idleness gets weaker. Everything the company sells follows from that one sentence.

How we do it

They design to a thin, flexible, wide last rather than to cushioning and control, and they put the resulting claims through universities rather than agencies. Vivobarefoot is named as industrial partner on an Innovate UK-funded research collaboration and appears in three peer-reviewed papers. It repairs and resells through ReVivo, runs an education platform in VivoHealth, and publishes an annual report that states plainly it has not yet achieved what it set out to.

What we do

Vivobarefoot designs and sells minimalist, 'barefoot' footwear for adults and children. Its product lines span lifestyle, active, and outdoor categories, with prices ranging from £130 to £180 on its UK site. Co-founded by Galahad Clark and Asher Clark, the company focuses on creating shoes that allow natural foot movement and strength.

Why it matters

The enemy is the belief that a weak foot should be propped up rather than trained, the same belief that sells more cushioning every year to people getting less capable underneath it. The victims are specific and countable: over 72,000 hip fractures a year in the UK per the Royal College of Physicians, more than fourteen million older Americans reporting a fall each year per the CDC. The enemy is a category norm, not any named competitor and not a partner.

Who it's for

A 68-year-old who has fallen over once already, has not told her daughter, and has started avoiding the stairs at the station. She has not heard of barefoot shoes and would find the phrase faintly ridiculous. She is the person in the published research and she is not in the advertising.

Proof points

Foot strength +57.4%, p<0.001, after six months' daily wear, 22 intervention vs 24 control (Curtis et al., Scientific Reports, 20 Sept 2021). Postural stability significantly better in minimal shoes in all directions measured, walking stability p<0.001, Timed Up and Go ~0.3s faster, n=30, mean age 68.6, all with a history of falls (Cudejko et al., Scientific Reports, 10 Dec 2020). Named industrial partner, Innovate UK grant 1570. B Corp certified 2020 at 98.8, recertified at 119.3 (company's own interim report 24/25). Turnover past €100m and roughly 70% founder-owned (Galahad Clark to FashionNetwork, 3 Sept 2026). Over 1 million customers (company figures, homepage, read 19 Sept 2026).

Traction & credibility

Three peer-reviewed papers across Scientific Reports and Clinical Biomechanics with the University of Liverpool. An Innovate UK research collaboration. B Corp since 2020. Minority investment from Sofina and from the manufacturer Stella. Retail in around twenty company-owned stores including a US flagship at 248 Lafayette Street, New York, and a US regional headquarters in Austin. Shoespiracy, the 2019 short film, has passed a million views across two cuts.

Spokespeople

Galahad Clark

Co Founder

Seventh-generation member of the Clark shoemaking family of Street, Somerset, whose ancestors founded Clarks in 1825. Worked with United Nude before developing barefoot prototypes from 2002 with Tim Brennan, a Royal College of Art graduate and Alexander Technique practitioner; approached Nike, Under Armour and Clarks before building the company independently. Launched Vivobarefoot as a standalone business in 2012.

Asher Clark

Co Founder

Cousin of Galahad Clark and also a seventh-generation member of the Clark shoemaking family. Co-founded Vivobarefoot and has led on footwear design; jointly holds approximately 70% of the company with Galahad Clark per FashionNetwork, 3 September 2026. Has spoken publicly on footwear design and the barefoot category in recorded interviews and conference talks.


Talking points

The insight

the science is about falling over. the marketing is about marathons.

vivobarefoot.com

The story

Five years ago today a Nature-portfolio journal published a study showing that six months of daily wear in Vivobarefoot shoes raised foot strength by 57.4%. A second paper in the same journal, with a consultant geriatrician among its authors and part-funded by Innovate UK, found that people with a history of falls stood and walked measurably more stably in the company's shoes than in conventional ones. Since then Britain has built a national falls apparatus — NICE guideline NG249, a Royal College of Podiatry policy costing falls at £4.4bn a year, and a hip fracture audit counting 72,000 fractures — and Vivobarefoot has spent the period selling to runners.

Why it matters

Falls are the most expensive avoidable event in an ageing health system and one of the least commercially served. A company holding published, publicly co-funded evidence in that space, and pointing it at marathon runners instead, is a case study in how consumer brands misprice their own assets.

Who does it impact

Five hundred barefoot brands now exist where four years ago there were about twenty; all of them can copy a thin sole, none can copy a peer-reviewed paper. For older people and the clinicians treating them, the question is whether footwear belongs in a falls conversation at all, which is a question the evidence raises and nobody has asked publicly.

Proof points

Curtis et al., Scientific Reports, 20 Sept 2021 (+57.4% foot strength, p<0.001). Cudejko, Gardiner, Akpan, D'Août, Scientific Reports, 10 Dec 2020 (stability and mobility, n=30, mean age 68.6, history of falls; Innovate UK grant 1570). Royal College of Physicians NHFD annual report, 10 Sept 2026 (72,000 fractures, one in thirty beds, £1.1bn). Royal College of Podiatry falls prevention policy, 7 Jul 2025 (£4.4bn). NICE NG249, 29 Apr 2025. CDC older adult falls data, updated Sept 2026.

CTA

Interviews: Galahad Clark and Asher Clark via Vivobarefoot

Get in touch

Asher Clark

Co Founder

Drop me a note and I'll reply by email.